SPARC.NS : Summary for SUN PHARMA ADV INR1 - Yahoo Finance

U.S. Markets closed

Sun Pharma Advanced Research Company Limited (SPARC.NS)


NSE - NSE Delayed Price. Currency in INR
Add to watchlist
320.50+0.40 (+0.12%)
As of 9:19AM IST. Market open.
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close320.10
Open320.95
Bid320.10 x
Ask320.40 x
Day's Range320.45 - 321.85
52 Week Range254.37 - 414.90
Volume2,128
Avg. Volume188,033
Market Cap79.1B
BetaN/A
PE Ratio (TTM)-80.27
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Reuterslast year

    U.S. DOJ antitrust unit subpoenas Mylan over pricing of doxycycline

    The antitrust division of the U.S. Department of Justice has subpoenaed Mylan N.V. for information relating to the pricing and marketing of its generic doxycycline antibiotic products, the drugmaker said on Friday. The Department of Justice has also sought information on any communication with competitors about the anti-bacterial products, the company said in a regulatory filing, adding it would cooperate with the federal agency. Competitors Endo International and Allergan Inc have also received similar subpoenas, according to regulatory filings made by them in November and August.

  • We're sorry this is all we were able to find about this topic.